| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |